ABIO Fundamental Analysis - Albioma SA

Name: Albioma SA (ABIO) Stock
Brand: Albioma SA
Rating: 5.5 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ABIO. ABIO was compared to 22 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and financial health of ABIO have multiple concerns. While showing a medium growth rate, ABIO is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ABIO was profitable.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	2.71%
ROE	9.81%
ROIC	5.3%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

		Industry Rank	Sector Rank
OM	19.98%
PM (TTM)	8.98%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABIO is creating some value.

Compared to 1 year ago, ABIO has more shares outstanding

ABIO has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that ABIO is in the distress zone and has some risk of bankruptcy.

A Debt/Equity ratio of 1.68 is on the high side and indicates that ABIO has dependencies on debt financing.

		Industry Rank	Sector Rank
Debt/Equity	1.68
Debt/FCF	N/A
Altman-Z	1.46

ROIC/WACC1.11

WACC4.79%

2.3 Liquidity

A Current Ratio of 1.05 indicates that ABIO should not have too much problems paying its short term obligations.

ABIO has a Quick Ratio of 1.05. This is a bad value and indicates that ABIO is not financially healthy enough and could expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	1.05
Quick Ratio	0.75

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ABIO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.36%.

Measured over the past years, ABIO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.59% on average per year.

Looking at the last year, ABIO shows a very strong growth in Revenue. The Revenue has grown by 21.04%.

Measured over the past years, ABIO shows a quite strong growth in Revenue. The Revenue has been growing by 9.28% on average per year.

EPS 1Y (TTM)4.36%

EPS 3Y8.34%

EPS 5Y10.59%

EPS Q2Q%-11.09%

Revenue 1Y (TTM)21.04%

Revenue growth 3Y10.21%

Revenue growth 5Y9.28%

Sales Q2Q%22.65%

3.2 Future

The Earnings Per Share is expected to grow by 7.39% on average over the next years.

Based on estimates for the next years, ABIO will show a small growth in Revenue. The Revenue will grow by 6.22% on average per year.

EPS Next Y4%

EPS Next 2Y10.38%

EPS Next 3Y7.07%

EPS Next 5Y7.39%

Revenue Next Year8.28%

Revenue Next 2Y6.4%

Revenue Next 3Y6.91%

Revenue Next 5Y6.22%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.94 indicates a quite expensive valuation of ABIO.

Compared to an average S&P500 Price/Earnings ratio of 26.13, ABIO is valued at the same level.

The Price/Forward Earnings ratio is 21.36, which indicates a rather expensive current valuation of ABIO.

The average S&P500 Price/Forward Earnings ratio is at 22.35. ABIO is around the same levels.

		Industry Rank	Sector Rank
PE	26.94
Fwd PE	21.36

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	11.89

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

PEG (NY)6.74

PEG (5Y)2.54

EPS Next 2Y10.38%

EPS Next 3Y7.07%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ABIO has a Yearly Dividend Yield of 1.78%. Purely for dividend investing, there may be better candidates out there.

ABIO's Dividend Yield is slightly below the S&P500 average, which is at 2.39.

		Industry Rank	Sector Rank
Dividend Yield	1.78%

5.2 History

On average, the dividend of ABIO grows each year by 8.92%, which is quite nice.

Dividend Growth(5Y)8.92%

Div Incr YearsN/A

Div Non Decr YearsN/A

5.3 Sustainability

ABIO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.

DPN/A

EPS Next 2Y10.38%

EPS Next 3Y7.07%

More info and screens

Find the best dividend stocks

Show peers with best dividend

Albioma SA

EPA:ABIO (9/13/2022, 7:00:00 PM)

47.14

+0.04 (+0.08%)

Chartmill FA Rating

GICS SectorUtilities

GICS IndustryGroupUtilities

GICS IndustryIndependent Power and Renewable Electricity Producers

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap1.52B

Revenue(TTM)633.91M

Net Income(TTM)56.94M

Analysts80

Price Target52.53 (11.43%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.78%

Yearly Dividend0.84

Dividend Growth(5Y)8.92%

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	26.94
Fwd PE	21.36
P/S	2.4
P/FCF	N/A
P/OCF	N/A
P/B	2.62
P/tB	N/A
EV/EBITDA	11.89

EPS(TTM)1.75

EY3.71%

EPS(NY)2.21

Fwd EY4.68%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS19.64

BVpS17.99

TBVpSN/A

PEG (NY)6.74

PEG (5Y)2.54

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	2.71%
ROE	9.81%
ROCE	N/A
ROIC	5.3%
ROICexc	N/A
ROICexgc	5.8%
OM	19.98%
PM (TTM)	8.98%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3Y0%

ROICexgc growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0.3

Health

		Industry Rank	Sector Rank
Debt/Equity	1.68
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.05
Quick Ratio	0.75
Altman-Z	1.46

F-Score6

WACC4.79%

ROIC/WACC1.11

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)4.36%

EPS 3Y8.34%

EPS 5Y10.59%

EPS Q2Q%-11.09%

EPS Next Y4%

EPS Next 2Y10.38%

EPS Next 3Y7.07%

EPS Next 5Y7.39%

Revenue 1Y (TTM)21.04%

Revenue growth 3Y10.21%

Revenue growth 5Y9.28%

Sales Q2Q%22.65%

Revenue Next Year8.28%

Revenue Next 2Y6.4%

Revenue Next 3Y6.91%

Revenue Next 5Y6.22%

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

Albioma SA / ABIO.PA FAQ

What is the fundamental rating for ABIO stock?

ChartMill assigns a fundamental rating of 5 / 10 to ABIO.PA.

What is the valuation status of Albioma SA (ABIO.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to Albioma SA (ABIO.PA). This can be considered as Overvalued.

Can you provide the profitability details for Albioma SA?

Albioma SA (ABIO.PA) has a profitability rating of 7 / 10.

What are the PE and PB ratios of Albioma SA (ABIO.PA) stock?

The Price/Earnings (PE) ratio for Albioma SA (ABIO.PA) is 26.94 and the Price/Book (PB) ratio is 2.62.

What is the expected EPS growth for Albioma SA (ABIO.PA) stock?

The Earnings per Share (EPS) of Albioma SA (ABIO.PA) is expected to grow by 4% in the next year.

Albioma SA (ABIO.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

Albioma SA / ABIO.PA FAQ

What is the fundamental rating for ABIO stock?

What is the valuation status of Albioma SA (ABIO.PA) stock?

Can you provide the profitability details for Albioma SA?

What are the PE and PB ratios of Albioma SA (ABIO.PA) stock?

What is the expected EPS growth for Albioma SA (ABIO.PA) stock?